| Abstract: | Hepatic resection is the most effective therapy for liver metastasis of colorectal carcinoma. To clarify indications for this
therapy, the clinicopathologic and follow-up data of 103 consecutive patients who underwent hepatic resection for metastases
of colorectal carcinoma were analyzed. Factors influencing overall survival rate were investigated by multivariate analysis.
Thereafter, patients who underwent resection were stratified according to the number of independent risk factors present,
and their outcomes were compared with those of 14 nonresection patients with fewer than six liver tumors and without extrahepatic
metastasis. The overall survival rate of the 103 resection patients was 43.1%. The clinicopathologic factors shown to affect
on long-term survival after hepatic resection were the interval between colorectal and hepatic surgery (<12 months), preoperative
carcinoembryonic antigen level (>-10 ng/ml), and number of hepatic metastases (four or more). The 5-year overall survival
rates were 75.0% with no risk factors (n = 16), 53.6% with one risk factor (n = 46), 23.0% with two risk factors (n = 36),
and0%with three risk factors (n = 5). Survival rates did not differ between resection patients with three risk factors and
nonresection patients. Therefore, hepatic resection may be appropriate for patients with fewer than three risk factors. |
